艾比瓦克斯

最新新闻

• 评级变动
  Truist Financial Maintains Abivax S.A.(ABVX.US) With Buy Rating, Maintains Target Price $135
  \u5e02\u573a\u8d44\u8baf · 2026/6/22
• Morgan Stanley Maintains Abivax S.A.(ABVX.US) With Buy Rating, Maintains Target Price $180
  \u5e02\u573a\u8d44\u8baf · 2026/9/28
• Goldman Sachs Initiates Abivax S.A.(ABVX.US) With Buy Rating, Announces Target Price $155
  \u5e02\u573a\u8d44\u8baf · 2026/9/10
• 评级变动
  Analysts Have Conflicting Sentiments on These Healthcare Companies: Bicara Therapeutics Inc. (BCAX), Abivax SA Sponsored ADR (ABVX) and Arcutis Biotherapeutics (ARQT)
  TipRanks · 2026/5/26
• 评级变动
  Piper Sandler Maintains Abivax S.A.(ABVX.US) With Buy Rating, Raises Target Price to $175
  \u5e02\u573a\u8d44\u8baf · 2026/7/9
• 评级变动
  Analysts Offer Insights on Healthcare Companies: HeartFlow, Inc. (HTFL), Taysha Gene Therapies (TSHA) and Abivax SA Sponsored ADR (ABVX)
  TipRanks · 2026/6/30
• 评级变动
  Jefferies Maintains Abivax S.A.(ABVX.US) With Buy Rating, Maintains Target Price $158
  \u5e02\u573a\u8d44\u8baf · 2026/7/1
• 评级变动
  Truist Financial Maintains Abivax S.A.(ABVX.US) With Buy Rating, Announces Target Price $155
  \u5e02\u573a\u8d44\u8baf · 2026/7/2
• 评级变动
  LifeSci Capital Maintains Abivax S.A.(ABVX.US) With Buy Rating, Maintains Target Price $170
  \u5e02\u573a\u8d44\u8baf · 2026/6/17
• Abivax 1H Loss EUR165.9M ABVX
  Dow Jones · 2026/9/22
• 评级变动
  A Quick Look at Today's Ratings for Abivax S.A.(ABVX.US), With a Forecast Between $110 to $175
  \u5e02\u573a\u8d44\u8baf · 2026/7/1
• 评级变动
  Barclays Maintains Abivax S.A.(ABVX.US) With Buy Rating, Maintains Target Price $148
  \u5e02\u573a\u8d44\u8baf · 2026/6/4
• 评级变动
  A Quick Look at Today's Ratings for Abivax S.A.(ABVX.US), With a Forecast Between $135 to $175
  \u5e02\u573a\u8d44\u8baf · 2026/6/16
• 评级变动
  A Quick Look at Today's Ratings for Abivax S.A.(ABVX.US), With a Forecast Between $132 to $187
  \u5e02\u573a\u8d44\u8baf · 2026/6/3
• 评级变动
  Analysts Are Bullish on These Healthcare Stocks: Biohaven Ltd. (BHVN), Abivax SA Sponsored ADR (ABVX)
  TipRanks · 2026/5/30
• BTIG Maintains Abivax S.A.(ABVX.US) With Buy Rating, Maintains Target Price $175
  \u5e02\u573a\u8d44\u8baf · 2026/10/2
• 评级变动
  Wolfe Research Maintains Abivax S.A.(ABVX.US) With Buy Rating, Cuts Target Price to $136
  \u5e02\u573a\u8d44\u8baf · 2026/6/4
• 评级变动
  Guggenheim Maintains Abivax S.A.(ABVX.US) With Buy Rating, Maintains Target Price $175
  \u5e02\u573a\u8d44\u8baf · 2026/7/2
• 评级变动
  Morgan Stanley Maintains Abivax S.A.(ABVX.US) With Buy Rating, Raises Target Price to $180
  \u5e02\u573a\u8d44\u8baf · 2026/7/24
• A Quick Look at Today's Ratings for Abivax S.A.(ABVX.US), With a Forecast Between $118 to $180
  \u5e02\u573a\u8d44\u8baf · 2026/9/23

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。